Jerome Frank Strauss, Iii

Title: Jerome Frank Strauss, III: Innovator in Lipoprotein Metabolism Treatment

Introduction

Jerome Frank Strauss, III is a notable inventor based in Wyndmoor, Pennsylvania. He has made significant contributions to the field of metabolic disorders, particularly in the treatment of defects in lipoprotein metabolism. With a total of seven patents to his name, Strauss has established himself as a key figure in medical innovation.

Latest Patents

One of Strauss's latest patents focuses on methods and compositions for the treatment of defects in lipoprotein metabolism. This invention provides a recombinant viral vector that comprises the DNA of, or corresponds to, at least a portion of the genome of an adenovirus. This portion is capable of infecting hepatic cells and includes a human VLDL receptor gene operatively linked to regulatory sequences that direct its expression. The vector is designed to express the normal VLDL receptor gene product in hepatic cells, both in vivo and in vitro. This viral vector is particularly useful in treating metabolic disorders caused by the accumulation of LDL in plasma, such as familial hypercholesterolemia or familial combined hyperlipidemia.

Career Highlights

Jerome Frank Strauss, III is affiliated with the University of Pennsylvania, where he continues to advance research in his field. His work has garnered attention for its potential to address significant health issues related to lipid metabolism.

Collaborations

Strauss has collaborated with esteemed colleagues, including James M. Wilson and Karen Kozarsky, to further enhance the impact of his research and innovations.

Conclusion

Jerome Frank Strauss, III is a prominent inventor whose work in lipoprotein metabolism treatment has the potential to transform medical approaches to metabolic disorders. His contributions through innovative patents and collaborations highlight the importance of research in improving health outcomes.